- Report
- June 2023
- 79 Pages
Italy
From €2098EUR$2,355USD£1,831GBP
- Book
- November 2024
North America
- Report
- March 2026
- 378 Pages
China
From €4320EUR$4,850USD£3,771GBP
- Report
- March 2026
- 167 Pages
Germany
From €4320EUR$4,850USD£3,771GBP
- Report
- March 2026
- 339 Pages
Canada
From €4320EUR$4,850USD£3,771GBP
- Report
- March 2026
- 206 Pages
India
From €4320EUR$4,850USD£3,771GBP
- Report
- March 2026
- 245 Pages
United States
From €4320EUR$4,850USD£3,771GBP
Point-of-Care Diagnostics (POCD) is a type of medical testing that is performed at or near the site of patient care. This type of testing is used to quickly diagnose and treat patients, often in a matter of minutes. POCD tests are typically small, portable, and easy to use, allowing healthcare providers to quickly and accurately diagnose a wide range of conditions.
POCD tests are used in a variety of settings, including hospitals, clinics, and even at home. These tests are often used to diagnose infectious diseases, such as influenza, HIV, and hepatitis, as well as to monitor chronic conditions, such as diabetes and hypertension. POCD tests can also be used to detect cancer, heart disease, and other conditions.
Some of the leading companies in the POCD market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Alere. These companies offer a wide range of POCD tests, ranging from simple blood tests to more complex molecular tests. Show Less Read more